Global Wearable Injectors Market Size study, By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery, Other), By Application (Oncology, Infectious Disease, Cardiovascular Disease, Autoimmune Disease, Other),

Global Wearable Injectors Market Size study, By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery, Other), By Application (Oncology, Infectious Disease, Cardiovascular Disease, Autoimmune Disease, Other), By End User (Hospital, Clinic, Home Care, Other), and Regional Forecasts 2022-2028

Global Wearable Injectors Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Wearable injectors (WIs) are a type of delivery system that adhere to the body to administer larger volumes of drug subcutaneously for a prolonged duration. The rising inclination towards healthcare delivery to homecare, increasing benefits of wearable injectors in the administration of various drugs, and growing incidences of chronic diseases are the chief factors that are bolstering the market growth across the globe. According to National Cancer Institute, in the year 2018, there were 18.1 million cancer patients were recorded, which is likely to rise to 29.5 million cases by the year 2040. Therefore, the growing prevalence of cancer is fueling the application of Wearable Injectors in the oncology segment, which is excelling the market growth in the near future. However, some concerns are associated with traditional infusion and injection technology and the presence of alternative drug delivery methods impedes the growth of the market over the forecast period of 2022-2028. Also, surging demand for biologics and MABs and rising technological advancements and design development are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Wearable Injectors Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the availability of advanced healthcare facilities and presence of well-established leading market players. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing prevalence of chronic diseases & lifestyle-related diseases, as well as the increasing favorable government initiatives for the use of various medical devices, would create lucrative growth prospects for the Wearable Injectors Market across the Asia-Pacific region.

Major market players included in this report are:
Becton, Dickinson and Company
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd.
Unilife Corporation
Steady Med Therapeutics, Inc.
Amgen Inc.
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc.
CeQur SA

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product Types of key players.

The detailed segments and sub-segment of the market are explained below:
By Type
On-body
Off-body
By Technology
Spring-based
Motor-driven
Rotary Pump
Expanding Battery
Other
By Application
Oncology
Infectious Disease
Cardiovascular Disease
Autoimmune Disease
Other
By End User
Hospital
Clinic
Home Care
Other
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Wearable Injectors Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Becton, Dickinson and Company
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd.
Unilife Corporation
Steady Med Therapeutics, Inc.
Amgen Inc.
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc.
CeQur SA

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.